You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

cediranib

Showing 1 - 25 of 25
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Solid Tumors Trial in Canada, United Kingdom (cediranib)

Active, not recruiting
  • Solid Tumors
  • cediranib
  • Edmonton, Alberta, Canada
  • +4 more
Sep 20, 2022

Ovarian Cancer Trial in Toronto (Cediranib, Olaparib)

Completed
  • Ovarian Cancer
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
May 3, 2022

Ovarian Cancer Trial in United Kingdom (Olaparib, Cediranib, Paclitaxel)

Active, not recruiting
  • Ovarian Cancer
  • Belfast, County Antrim, United Kingdom
  • +13 more
Feb 22, 2022

Carcinosarcoma, Endometrial Tumors Trial in United Kingdom (Paclitaxel, Cediranib, Olaparib)

Active, not recruiting
  • Carcinosarcoma
  • Endometrial Neoplasms
  • Northwood, Middlesex, United Kingdom
  • +14 more
Feb 10, 2022

Advanced Breast Carcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 Trial in Houston

Recruiting
  • Advanced Breast Carcinoma
  • +14 more
  • Cediranib
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Mar 31, 2022

Ovarian Cancer Trial in Worldwide (Olaparib, Cediranib)

Recruiting
  • Ovarian Cancer
  • Sydney, New South Wales, Australia
  • +53 more
Sep 26, 2022

Recurrent Glioblastoma Trial in United States (Bevacizumab, Cediranib, Cediranib Maleate)

Active, not recruiting
  • Recurrent Glioblastoma
  • Bevacizumab
  • +3 more
  • La Jolla, California
  • +26 more
Jun 28, 2022

Refractory Differentiated Thyroid Gland Carcinoma, Refractory Thyroid Gland Follicular Carcinoma, Refractory Thyroid Gland

Completed
Has Results
  • Refractory Differentiated Thyroid Gland Carcinoma
  • +4 more
  • Cediranib
  • +3 more
  • Duarte, California
  • +32 more
Jun 24, 2021

Ovarian Cancer Trial in Manchester (Olaparib, Cediranib, Platinum-based Chemotherapy)

Completed
  • Ovarian Cancer
  • Manchester, United Kingdom
    The Christie NHS Foundation Trust
Feb 4, 2022

Extensive Stage Lung Small Cell Carcinoma Trial in United States (Carboplatin, Cediranib, Cediranib Maleate)

Terminated
Has Results
  • Extensive Stage Lung Small Cell Carcinoma
  • Los Angeles, California
  • +23 more
Mar 22, 2021

Renal Cell Cancer Trial in Cambridge (Olaparib, Cediranib, Durvalumab)

Recruiting
  • Renal Cell Cancer
  • Cambridge, England, United Kingdom
    Addenbrooke's Hospital
May 21, 2021

Endometrial Cancer, Ovarian Cancer, Cervical Cancer Trial in Boston (temsirolimus, cediranib)

Completed
  • Endometrial Cancer
  • +4 more
  • Boston, Massachusetts
  • +2 more
Apr 20, 2021

Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube Serous Adenocarcinoma Trial

Active, not recruiting
  • Fallopian Tube Clear Cell Adenocarcinoma
  • +14 more
  • Cediranib
  • +9 more
  • Birmingham, Alabama
  • +399 more
Dec 30, 2022

Endometrial Undifferentiated Carcinoma, Endometrioid Adenocarcinoma, Recurrent Endometrial Serous Adenocarcinoma Trial in United

Recruiting
  • Endometrial Undifferentiated Carcinoma
  • +6 more
  • Birmingham, Alabama
  • +741 more
Feb 2, 2023

Ovarian Tumors Trial in Italy (Paclitaxel, Cediranib, Olaparib)

Unknown status
  • Ovarian Neoplasms
  • Brescia, BS, Italy
  • +5 more
May 13, 2019

Alveolar Soft-part Sarcoma Trial in Australia, Spain, United Kingdom (Cediranib, Placebo)

Unknown status
  • Alveolar Soft-part Sarcoma
  • Cediranib
  • Placebo
  • Brisbane, Australia
  • +10 more
Jan 22, 2019

Ovarian Cancer Trial in Toronto (Olaparib, Cediranib)

Completed
  • Ovarian Cancer
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Jun 11, 2018

Renal Cell Carcinoma Trial in Netherlands, United Kingdom (Cediranib, Cediranib Placebo)

Completed
Has Results
  • Renal Cell Carcinoma
  • Cediranib
  • Cediranib Placebo
  • Groningen, Netherlands
  • +7 more
Dec 8, 2016

Recurrent Glioblastoma Trial in Worldwide (Cediranib, Lomustine Chemotherapy, Placebo Cediranib)

Completed
Has Results
  • Recurrent Glioblastoma
  • Cediranib
  • +2 more
  • Birmingham, Alabama
  • +61 more
Nov 7, 2016

Metastatic Colorectal Cancer Trial in Worldwide (Cediranib, FOLFOX (5-fluorouracil, Leucovorin, Oxaliplatin), XELOX

Completed
Has Results
  • Metastatic Colorectal Cancer
  • Cediranib
  • +3 more
  • Buenos Aires City, Argentina
  • +90 more
Nov 7, 2016

Ovarian Cancer Trial in London (cediranib)

Unknown status
  • Ovarian Cancer
  • cediranib
  • London, Greater London, United Kingdom
    University College London
Sep 21, 2015

Biliary Tract Tumors Trial in London, Manchester (gemcitabine, cisplatin, Placebo)

Completed
  • Biliary Tract Neoplasms
  • London, United Kingdom
  • +1 more
Oct 24, 2014

Cancer Trial in United Kingdom (Cediranib, Cediranib 30 - 90 mg)

Completed
Has Results
  • Cancer
  • Cediranib
  • Cediranib 30 - 90 mg
  • Glasgow, United Kingdom
  • +3 more
Oct 3, 2012

Gastric Cancer Trial in Japan (Cediranib, Cisplatin, S-1)

Completed
  • Gastric Cancer
  • Cediranib
  • +3 more
  • Nagoya, Aichi, Japan
  • +3 more
Jun 13, 2011

Recurrent Glioblastoma, Brain Tumor Trial in Boston, Sutton (Cediranib, Lomustine)

Completed
  • Recurrent Glioblastoma
  • Brain Tumor
  • Boston, Massachusetts
  • +1 more
Nov 24, 2009